FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT06609928 · RECRUITING

Trial details

NCT number: NCT06609928
Sponsor: Fred Hutchinson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Childhood Acute Myeloid Leukemia Refractory Childhood Acute Myeloid Leukemia

Start date: 2025-02-24
Primary completion: 2027-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.